HUM vs INGN · P/E 39, rev $117.76B vs rev $335.7M
Humana Inc (HUM) versus Inogen Inc (INGN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Inogen Inc (INGN) is a medical devices company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported INGN revenue for 2024-12-31 was $335.7M. Net income was -$35.9M. Revenue was up 6.4% from 2023-12-31 to 2024-12-31. INGN currently screens at market cap $173.5M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. INGN currently screens at market cap $173.5M.
Not investment advice. Open the HUM and INGN stock pages for the full models.
Not investment advice.